Background Acute kidney injury (AKI) is a frequent and severe complication of both COVID-19-related acute respiratory distress syndrome (ARDS) and non-COVID-19-related ARDS. The COVID-19 Critical Care Consortium (CCCC) has generated a global data set on the demographics, management and outcomes of critically ill COVID-19 patients. The LUNG-SAFE study was an international prospective cohort study of patients with severe respiratory failure, including ARDS, which pre-dated the pandemic. Methods The incidence, demographic profile, management and outcomes of early AKI in patients undergoing invasive mechanical ventilation for COVID-19-related ARDS were described and compared with AKI in a non-COVID-19-related ARDS cohort. Results Of 18,964 patients in the CCCC data set, 1699 patients with COVID-19-related ARDS required invasive ventilation and had relevant outcome data. Of these, 110 (6.5%) had stage 1, 94 (5.5%) had stage 2, 151 (8.9%) had stage 3 AKI, while 1214 (79.1%) had no AKI within 48 h of initiating invasive mechanical ventilation. Patients developing AKI were older and more likely to have hypertension or chronic cardiac disease. There were geo-economic differences in the incidence of AKI, with lower incidence of stage 3 AKI in European high-income countries and a higher incidence in patients from middle-income countries. Both 28-day and 90-day mortality risk was increased for patients with stage 2 (HR 2.00, p < 0.001) and stage 3 AKI (HR 1.95, p < 0.001). Compared to non-COVID-19 ARDS, the incidence of shock was reduced with lower cardiovascular SOFA score across all patient groups, while hospital mortality was worse in all groups [no AKI (30 vs 50%), Stage 1 (38 vs 58%), Stage 2 (56 vs 74%), and Stage 3 (52 vs 72%), p < 0.001]. The time profile of onset of AKI also differed, with 56% of all AKI occurring in the first 48 h in patients with COVID-19 ARDS compared to 89% in the non-COVID-19 ARDS population. Conclusion AKI is a common and serious complication of COVID-19, with a high mortality rate, which differs by geo-economic location. Important differences exist in the profile of AKI in COVID-19 versus non-COVID-19 ARDS in terms of their haemodynamic profile, time of onset and clinical outcomes.
Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies / M. Bairbre A., R. Emanuele, S. Andrew J., K. Sankalp, S. Jacky Y., Y. Pauline, B. Daniel, B. Gianluigi Li, P. Tai, B. Giacomo, F. John F., L. John, C. Cccc, T. Al-Dabbous, H. Alfoudri, M. Shamsah, Q. Alhadad, M. Hanan, S. Elapavaluru, A. Berg, C. Horn, A. Reda Mohamed Elsayed Abdelhalim, A. Essam Amer, C. Omar Rageh Elnaggar, A. Ayman Hassan, A. Abdelaziz, M. Abdelhalim, Y. Samir Shaaban Aly Orabi, Z.A. Alaraji, M.R. Muhaisen, L. Almasri, D. Mustafa, S. Hamdan, Y. Al-Saba’a, Z. Dalloul, M. Alkahlout, H. Jaber, O. Aldabbourosama, A.A.R. Mohamed Hussein, Z. Kamel Emad, S. Khaled, N. Mohamed, E. Hassanin, A. Hamdi, A. Ragab, M.G. Azizeldin, Y. Mayasi, S. Schroll, D. Meyer, J. Velazco, L. Ploskanych, W. Fikes, R. Bagewadi, M. Dao, H. White, A. Berrios Laviena, A. Ehlers, M. Shalabi-McGuire, T. Witt, L. Grazioli, L. Lorini, E. Wilson Grandin, J. Nunez, T. Reyes, D. O’Briain, S. Hunter, M. Ramanan, J. Affleck, H. Hurkadli Veerendra, S. Rai, J. Russell-Brown, M. Nourse, M. Joseph, B. Mitchell, M. Tenzer, R. Abe, H. Jin Cho, I. Seok Jeong, N. Rahman, V. Kakar, H. Sun, A. Hanley, N. Brozzi, O. Mehkri, S. Krishnan, A. Duggal, S. Houltham, J. Graf, R. Diaz, R. Orrego, C. Delgado, J. González, M. Soledad Sanchez, M. Piagnerelli, J. Valenzuela Sarrazin, G. Zabert, L. Espinosa, P. Delgado, V. Delgado, D. Fernando Bautista Rincón, A. Maria Marulanda Yanten, M. Bustamante Duque, D. Brodie, K. Abouelmagd, A. Elhazmi, A. Al-Hudaib, J. Javidfar, M. Callahan, A. Dong, C. Crepy D’Orleans, M. Azhari Taufik, E. Yasmin Wardoyo, M. Gunawan, N.S. Trisnaningrum, V. Irawany, M. Rayhan, M. Panigada, A. Pesenti, A. Zanella, G. Grasselli, S. Colombo, C. Martinet, G. Florio, M. Antonelli, S. Carelli, D.L. Grieco, M. Asaki, K. Hoshino, L. Salazar, M. Alejandra Mendoza Monsalve, J. Laffey, B. Mcnicholas, D. Cosgrave, M. Atif, F. Qutishat, C. Laffey, M. Van Der Walt, J. Mccaffrey, A. Bone, Y. Hakeem, J. Winearls, M. Tallott, D. Thomson, I. Joubert, C. Arnold-Day, J. Piercy, R. Van Zyl Smit, M. Miller, L. Seymour, F. Van Heyningen, G. Teyangesikayi, D. Fredericks, A. Ait Hssain, J. Aliudin, A. Alqahtani, K. Mohamed, A. Mohamed, D. Tan, J. Villanueva, A. Zaqout, E. Kurtzman, A. Ademi, A. Dobrita, K. El Aoudi, J. Segura, G. Giwangkancana, S. Ohshimo, J. Osatnik, A. Joosten, A. Torres, M. Yang, A. Motos, C. Luna, F. Arancibia, V. Williams, A. Noel, N. Luque, M. Fantini, R. Noemi Jorge García, E. Chicote Alvarez, A. Greti, A. Ceccato, A. Sanchez, A. Loza Vazquez, F. Roche-Campo, D. Franch-Llasat, D. Tuazon, M. Amato, L. Cassimiro, F. Pola, F. Ribeiro, G. Fonseca, H. Dalton, M. Desai, E. Osborn, H. Deeb, A. Arcadipane, G. Martucci, G. Panarello, S. Vitiello, C. Bianco, G. Occhipinti, M. Rossetti, R. Cuffaro, S. Cho, G. Whitman, M. El Sayed, W. Mokhtar, E. El-Shenawy, H. Shimizu, N. Moriyama, J. Kim, N. Kitamura, J. Gebauer, T. Yokoyama, A. Al-Fares, S. Buabbas, E. Alamad, F. Alawadhi, K. Alawadi, M. Ahmed Khalefa, N. Ahmad Abdulaziz Al Ajeel, M. Fathy Aly, A. Al-Saleh, A. Naanouh, A. Mohammed Elshourbgy, A. Al-Fares, M. Yousef Gad, R. Mohamed Elrazaz, I. Khadadah, A. Mohammed Almumin, H. Altarakma, H. Albannay, M. Kh Alsaleh, M. Saad Abdallah Radwan, I. Ahmed Saadallah, H. Tanaka, S. Hashimoto, M. Yamazaki, T. Oh, M. Epler, C. Forney, L. Kruse, J. Feister, J. Williamson, K. Grobengieser, E. Gnall, S. Golden, M. Caroline, T. Shapiro, C. Karaj, L. Thome, L. Sher, M. Vanderland, M. Welch, S. Mcdermott, M. Brain, S. Mineall, M. Unwin, L. Chen, T. Trezise, L. Mckeon, D. Kimura, L. Brazzi, G. Sales, G. Montrucchio, T. Ogston, D. Nagpal, K. Fischer, R. Lorusso, B. Van Bussell, M. Elena De Piero, S. Mariani, R. Rangappa, R. Mohan Shetty, P. Sujin Rai, A. Ganesan, M. Esperatti, N. Angélica Fuentes, M. Eugenia Gonzalez, D. O’Briain, E.G. Carton, A. Sen, A. Palacios, D. Rainey, G. Samoukoviv, J. Campisi, L. Durham, E. Neumann, C. Seefeldt, O. Falcucci, A. Emmrich, J. Guy, C. Johns, K. Potzner, C. Zimmermann, A. Espinal, N. Buchtele, M. Schwameis, A. Korhnfehl, R. Brock, T. Staudinger, S. Stecher, M. Barnikel, S. Antón, A. Pawlikowski, A. Zaaqoq, L. Anh Galloway, C. Merley, A. Nichol, M. Csete, L. Quesada, I. Saba, D. Kasugai, H. Hiraiwa, T. Tanaka, E. Marwali, Y. Purnama, S. Rahayu Dewayanti, Ardiyan, D. Arifa Juzar, D. Siagian, Y. Chen, M. Ogino, P. Nasa, C. Matthew, N. Abdul Majeed, I. Ratsep, A. Post, P. Sillaots, A. Krund, M. Lehiste, T. Lepik, F. Manetta, E. Mihelis, I. Claire Sarmiento, M. Narasimhan, M. Varrone, M. Komats, J. Garcia-Diaz, C. Harmon, S. Veena Satyapriya, A. Bhatt, N.A. Mokadam, A. Uribe, A. Gonzalez, H. Shi, J. Mckeown, J. Pasek, J. Fiorda, M. Echeverria, R. Moreno, B. Zakhary, M. Cavana, A. Cucino, G. Foti, M. Giani, B. Fumagalli, D. Chiumello, V. Castagna, A. Dell’Amore, P. Navalesi, H. Shum, A. Vuysteke, A. Usman, A. Acker, B. Smood, B. Mergler, F. Sertic, M. Subramanian, A. Sperry, N. Rizer, E. Burhan, M. Rasmin, E. Akmal, F. Sitompul, N. Lolong, B. Naivedh, S. Erickson, P. Barrett, D. Dean, J. Daugherty, A. Loforte, I. Khan, M. Abraar Quraishi, O. Desantis, D. So, D. Kandamby, J.M. Mandei, H. Natanael, E. Yudhalantang, A. Lantang, S. Oto Wijaya, A. Jung, G. Ng, W. Yiu Ng, P. Yeung Ng, S. Fang, A. Tabah, M. Ratcliffe, M. Duroux, A. Alajeeli, A. Tarhabat, S. Adachi, S. Nakao, P. Blanco, A. Prieto, J. Sánchez, M. Nicholson, W. Butt, A. Serratore, C. Delzoppo, P. Janin, E. Yarad, R. Totaro, J. Coles, B. Pujo, R. Balk, A. Vissing, E. Kapania, J. Hays, S. Fox, G. Yantosh, P. Mishin, S. Yuliarto, K. Hari Santoso, S. Djajalaksana, A. Zainul Fatoni, M. Fukuda, K. Liu, P. Pelosi, D. Battaglini, J. Fernando Masa Jiménez, D. Bastos, S. Gaião, D. Rusmawatiningtyas, Y. Cho, S. Hwan Lee, T. Kawasaki, L. Munshi, P. Sakiyalak, P. Nitayavardhana, M. Bashir Elagili, T. Ahmed Abu Salem, T. Seitz, R. Arora, D. Kent, D. Marino, S. Parwar, A. Cheng, J. Miller, S. Fujitani, N. Shimizu, J. Madhok, C. Owyang, H. Buscher, C. Reynolds, O. Maasikas, Aleksanbeljantsev, V. Mihnovits, T. Akimoto, M. Aizawa, K. Horibe, R. Onodera, C. Hodgson, A. Burrell, M. Young, T. George, K. Shekar, N. Mcguinness, L. Irvine, B. Flynn, T. Endo, K. Sugiyama, K. Shimizu, E. Fan, K. Exconde, S. Ichiba, M. Binnawara, L. Lussier, G. Lotz, M. Malfertheiner, L. Maier, E. Dreier, N. Permata Kusumastuti, C. Mccloskey, A. Dabaliz, T.B. Elshazly, J. Smith, K.S. Szuldrzynski, P. Bielański, Y. Hakeem, K. Wille, S. Murthy, K.K.S. Parhar, K.M. Fiest, C. Codan, A. Shahid, M. Fayed, T. Evans, R. Garcia, A. Gutierrez, H. Shimizu, T. Song, R. Rose, S. Bennett, D. Richardson, G. Peek, L. Arora, K. Rappapport, K. Rudolph, Z. Sibenaller, L. Stout, A. Walter, D. Herr, N. Vedadi, R. Bartlett, A. Pesenti, S. Thompson, J. Hoffman, X. Ying, B. Williams, E. Sanchez, C. Akwani, R. Kennedy, M. Elhadi, M. Griffee, M. Mone, A. Ciullo, Y. Kida, R. Ferrer Roca, J. Riera, S. Contreras, C. Alegre, C. Kay, I. Fischer, E. Renner, H. Taniguci, J. Lee, D. Plotkin, B. Wanjiru Citarella, L. Merson, E. Hartley, B. Lubis, T. Ikeyama, A. Alhamad, M. Fathi, M. Maher Hadhoud, H. Alhouri, A. Mechi, M. Saleh Alyasiri, M. Zainab Alghali Elsaid, H. Shahla, B. Bhaskar, J. Jung, S. Mcguinness, G. Eastwood, S. Rossi Marta, F. Guarracino, S. Gerle, E. Coxon, B. Claro, M. Eleisawy, H. Osama, D. Loverde, N. Patil, V. Parrini, A. Mcbride, K. Negaard, A. Ratsch, A. Abdelaziz, J. David Uribe, A. Peris, M. Sanders, D. Emerson, M. Kamal, H. Faida, P. Povoa, R. Francis, A. Cherif, S. Joseph, M. Di Nardo, M. Heard, K. Kyle, R.A. Blackwell, A. Ouyahia, M. Piagnerelli, P. Biston, H. Won Jeong, R. Smith, Y. Prawira, G. Montrucchio, A. Huerta Garcia, N. Salterain, B. Meyns, M. Elnasser, M. Moreno, R. Walia, A. Mehta, A. Schweda, M. Williams, E. Amkhatirah, K. Hoon Kim, A. Assad, E. Giraldo, W. Karolak, M. Balik, E. Pocock, A. Mohamed, E. Gajkowski, K. Masafumi, N. Barrett, Y. Takeyama, S. Park, F. Amin, F. Meilyana Andriyani, S. Sudakevych, J. Schnur, A. Ratsch, M. Vera, R. Cornejo, P. Schwarz, A. Carolina Mardini, T. De Paula, A. Serpa Neto, A. Villoldo, A. Siciliano Colafranceschi, A. Ubeda Iglesias, J. Granjean, L. Maria Garcia Melro, G. Fioravante Romualdo, D. Gaia, H. Souza, F. Galas, R. Máñez Mendiluce, A. Sosa, I. Martinez, H. Kurosawa, M. Badr Almoshantaf, J. Salgado, B. Hugi-Mayr, E. Charbonneau, V. Salvatore Barzilai, V. Monteiro, R. Ribeiro De Souza, M. Harper, N. Siddig, H. Suzuki, C. Adams, J. Brieva, A. Khamees, F. Graige, M. Supriatna, G. Nyale, F. Saleem Eltatar, J. Fatani, H. Baeissa, A.A.L. Masri, A. Rabie, M. Yee Hui, M. Yamane, H. Jung, A. Mojisola Margaret, N. Nacpil, K. Ruck, R. Bakken, C. Jara, T. Felton, S. Tharwat, L. Berra, B. Shah, A. Chakraborty, M. Cardona, G. Capatos, B. Akkanti, A. Orija, H. Jain, A. Ito, M. Muftah, B. Housni, A. Aldhalia, S. Low, K. Iihara, J. Chavez, K. Ramanathan, G. Zabert, K. Naidoo, I. Seppelt, M. Vandyk, S. Macdonald, S. Ichiba, W. Hafez, R. Mcgregor, T. Siebenaler, H. Flynn, K. Lofton, T. Aokage, B. Kvirkvelia, K. Shigemitsu, A. Moscatelli, G. Fiorentino, M. Baumgaertel, S. Eddy Mba, J. Assy, A. Hutahaean, H. Roush, K.A. Sichting, F. Alessandri, D. Burns, T. Husayn Alkhubouli, A. Nasrallah, A. Rabie, G. Salt, C.P. Garabedian, J. Millar, M. Sim, A. Mattke, D. Mcauley, J. Tadili, T. Frenzel, Y. Bar-Lavie, A. Blandino Ortiz, J. Stone, A. Tabah, A. Attokaran, M. Farquharson, B. Patel, D. Gunning, K. Baillie, S. Adem, P. Watson, K. Tamai, G. Ketut Sajinadiyasa, D. Kanyawati, M. Salgado, A. Sassine, B. Yudo, S. Mccaul, B. Lee, S. Min Lee, A. Afek, Y. Iwashita, H. Fadlalmola, B. Pujo Semedi, N. Permata Kusumastuti, N. Mohamed Mansour, J. Metiva, N. Van Belle, I. Martin-Loeches, M. Al-Sadawi, C. Kirakli, A. Shimaa, A. Abdurraouf, L. Ivatt, S. Moharam, C. Yew Woon, H. Mi Kang, T. Smith, E. James, N. Al-Rawas, A. Almjersah, Y. Iwasaki, H. Ashour, H. Embarek, K. Chan King-Chung, V. Gudzenko, B. Hugi-Mayr, F. Taccone, F. Perdhana, Y. Lamarche, J. Miguel Ribeiro, N. Bradic, K. Van Den Bossche, O. Lansink, G. Singh, G. Debeuckelaere, H.T. Stelfox, C. Yi, J. Elia, T. Tribble, S. Shankar, R. Padmanabhan, B. Hallinan, L. Paoletti, Y. Leyva, T. Fykuda, J. Badulak, J. Koch, L. Janowaik, A. Hackman, D. Hernandez, J. Osofsky, K. Donadello, A. Lawang, J. Fine, B. Davidson, A. Oswaldo Razo Vazquez &, I. Abdehaleem. - In: CRITICAL CARE. - ISSN 1364-8535. - 27:(2023), pp. 3.1-3.14. [10.1186/S13054-023-04487-6]
Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies
S. Colombo;
2023
Abstract
Background Acute kidney injury (AKI) is a frequent and severe complication of both COVID-19-related acute respiratory distress syndrome (ARDS) and non-COVID-19-related ARDS. The COVID-19 Critical Care Consortium (CCCC) has generated a global data set on the demographics, management and outcomes of critically ill COVID-19 patients. The LUNG-SAFE study was an international prospective cohort study of patients with severe respiratory failure, including ARDS, which pre-dated the pandemic. Methods The incidence, demographic profile, management and outcomes of early AKI in patients undergoing invasive mechanical ventilation for COVID-19-related ARDS were described and compared with AKI in a non-COVID-19-related ARDS cohort. Results Of 18,964 patients in the CCCC data set, 1699 patients with COVID-19-related ARDS required invasive ventilation and had relevant outcome data. Of these, 110 (6.5%) had stage 1, 94 (5.5%) had stage 2, 151 (8.9%) had stage 3 AKI, while 1214 (79.1%) had no AKI within 48 h of initiating invasive mechanical ventilation. Patients developing AKI were older and more likely to have hypertension or chronic cardiac disease. There were geo-economic differences in the incidence of AKI, with lower incidence of stage 3 AKI in European high-income countries and a higher incidence in patients from middle-income countries. Both 28-day and 90-day mortality risk was increased for patients with stage 2 (HR 2.00, p < 0.001) and stage 3 AKI (HR 1.95, p < 0.001). Compared to non-COVID-19 ARDS, the incidence of shock was reduced with lower cardiovascular SOFA score across all patient groups, while hospital mortality was worse in all groups [no AKI (30 vs 50%), Stage 1 (38 vs 58%), Stage 2 (56 vs 74%), and Stage 3 (52 vs 72%), p < 0.001]. The time profile of onset of AKI also differed, with 56% of all AKI occurring in the first 48 h in patients with COVID-19 ARDS compared to 89% in the non-COVID-19 ARDS population. Conclusion AKI is a common and serious complication of COVID-19, with a high mortality rate, which differs by geo-economic location. Important differences exist in the profile of AKI in COVID-19 versus non-COVID-19 ARDS in terms of their haemodynamic profile, time of onset and clinical outcomes.| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream--1064567288.pdf
accesso aperto
Descrizione: correction
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
710.35 kB
Formato
Adobe PDF
|
710.35 kB | Adobe PDF | Visualizza/Apri |
|
s13054-022-04294-5.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
1.7 MB
Formato
Adobe PDF
|
1.7 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




